Wu Dandan, Chen Yang, Chen Qiming, Wang Guoming, Xu Xiaofeng, Peng A, Hao Jin, He Jinguang, Huang Li, Dai Jiewen
Department of Oral and Cranio-maxillo facial Surgery, National Clinical Research Center for Oral Disease, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, People's Republic of China.
J Genet. 2019 Jun;98(2).
Diagnosis and treatment of velocardiofacial syndrome (VCFS) with variable genotypes and phenotypes are considered to be very complicated. Establishing an exact correlation between the phenotypes and genotypes of VCFS is still a challenging. In this paper, 88 Chinese VCFS patients were divided into five groups based on palatal anomalies and one or two of other four common phenotypes, and copy number variations (CNVs) were detected using multiplex ligation-dependent probe amplification (MLPA), array comparative genomic hybridization (aCGH) and quantitative polymerase chain reaction. The findings showed that palatal anomalies and characteristic malformation of face were important indicators for 22q11.2 microdeletion, and there was difference inthe phenotypic spectrum between the duplication and deletion of 22q11.2. MLPA was a highly cost-effective, sensitive and preferred method for patients with 22q11.2 deletion or duplication. Our results also firstly reported that all three patients who simultaneously exhibited palatal anomalies and cognitive disorder, without other phenotypes, have Top3b duplication, which strongly suggested that Top3b may be a pathogenic gene for these patients. Further, the findings showed that patients with palatal anomalies and congenital heart disease or immune deficiency, with or without other uncommon phenotypes, exhibited heterogeneity in CNVs, including 4q34.1-qter, 6q25.3, 4q23, Xp11.4, 13q21.1, 17q23.2, 7p21.3, 2p11.2, 11q24.3 and 16q23.3, and some possible pathogenic genes, including , , , , and have been suggested. For these patients, aCGH, whole genomic sequencing,combined with references and phenomics database to find pathogenic gene,may be choices of priority. Taking these findings together, we offered an alternative method for diagnosis of Chinese VCFS patients based on this phenotypic strategy.
具有可变基因型和表型的腭心面综合征(VCFS)的诊断和治疗被认为非常复杂。在VCFS的表型和基因型之间建立确切的相关性仍然具有挑战性。在本文中,88例中国VCFS患者根据腭部异常以及其他四种常见表型中的一种或两种被分为五组,并使用多重连接依赖探针扩增(MLPA)、阵列比较基因组杂交(aCGH)和定量聚合酶链反应检测拷贝数变异(CNV)。研究结果表明,腭部异常和面部特征性畸形是22q11.2微缺失的重要指标,并且22q11.2的重复和缺失之间的表型谱存在差异。MLPA是检测22q11.2缺失或重复患者的一种高性价比、敏感且首选的方法。我们的结果还首次报道,所有同时表现出腭部异常和认知障碍且无其他表型的三名患者均有Top3b重复,这强烈表明Top3b可能是这些患者的致病基因。此外,研究结果表明,有腭部异常和先天性心脏病或免疫缺陷的患者,无论有无其他罕见表型,在CNV方面表现出异质性,包括4q34.1-qter、6q25.3、4q23、Xp11.4、13q21.1、17q23.2、7p21.3、2p11.2、11q24.3和16q23.3,并且已经提出了一些可能的致病基因,包括 、 、 、 、 和 。对于这些患者,aCGH、全基因组测序,结合参考文献和表型组学数据库来寻找致病基因,可能是优先选择。综合这些发现,我们基于这种表型策略为中国VCFS患者的诊断提供了一种替代方法。